Ruth McKernan has been appointed chair of Cumulus Neuroscience Ltd of Belfast, UK which has a platform for generating biomarkers for trials of drugs for central nervous system disorders. Dr McKernan is a venture partner at the Dementia Discovery Fund (DDF) which invests in companies investigating age-related dementias. Prior to joining DDF, she was chief executive of the UK government’s innovation agency, Innovate UK. In earlier years, she held executive positions at both Pfizer and Merck & Co Inc. At Merck, she was head of the company’s neuroscience research center. Dr McKernan is the author of more than 120 scientific papers and 15 patents.
Cumulus announced the appointment on 14 September 2021.
Copyright 2021 Evernow Publishing Ltd